| Sign In to gain access to subscriptions and/or personal tools. |
Outcome after coronary artery bypass surgery with miniaturized versus conventional cardiopulmonary bypassDepartment of Anesthesiology, Oulu University Hospital, Oulu, Finland
Department of Surgery, Oulu University Hospital, Oulu, Finlandfaustobiancari{at}yahoo.it
Department of Anesthesiology, Vaasa Central Hospital, Vaasa, Finland
Department of Surgery, Vaasa Central Hospital, Vaasa, Finland
Department of Anesthesiology, Vaasa Central Hospital, Vaasa, Finland
Department of Surgery, Oulu University Hospital, Oulu, Finland
Department of Surgery, Vaasa Central Hospital, Vaasa, Finland
Department of Surgery, Vaasa Central Hospital, Vaasa, Finland
We have reviewed the results of our experience with the use of miniaturized (Mini-CPB) versus conventional (C-CPB) cardiopulmonary bypass in coronary artery bypass surgery (CABG). This study included 365 patients who underwent CABG with C-CPB and 101 patients with Mini-CPB. In-hospital mortality was lower in the C-CPB group (1.4% vs. 3.0%, P = 0.38). A better, but not statistically significant, immediate outcome was observed in the C-CPB group as indicated by a shorter length of stay in the intensive care unit as well as a lower incidence of combined adverse end-point. However, this was probably due to significantly higher operative risk in the Mini-CPB group (logistic EuroSCORE: 8.5 ± 10.0 vs. 4.6 ± 7.1, P < 0.0001). Seventy-seven propensity score-matched pairs had similar immediate postoperative results after Mini-CPB and C-CPB (30-day mortality: 1.3% vs. 1.3%; stroke: 0% vs. 0%; intensive care unit stay
Perfusion, Vol. 23, No. 6,
361-367 (2008) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 days: 6.5% vs. 9.1%; combined adverse events: 14.3% vs. 11.7%). Mini-CPB achieves similar results to C-CPB in patients undergoing isolated CABG. The potential efficacy of Mini-CPB is expected to be more evident in high-risk patients or in complex cardiac surgery requiring much longer cardiopulmonary perfusion.